Jan 2, 2019 12:23 PM
FDA issued recall of CAmlodipine/Valsartan Tablets USP, Valsartan/HCTZ Tablets, USP and Valsartan Tablets USP by Aurobindo due to NDEA (N-Nitrosodiethylamine) impurity.
More on the FDA website:
www.fda.gov/Safety/Recalls/ucm629213.htm